Legacy Reserves LGCY Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number

Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number at other companies

BioSig Technologies, Inc.STEX

——

Revenue$21.4M+15.0%

Operating income$3.9M+7.6%

Net income$3.0M+7.5%

EPS (diluted)$0.22+4.8%

Cash & equivalents$21.7M+25.1%

Total debt$15.5M-13.3%

Total equity$49.5M+26.1%

Total assets$75.5M+12.5%

Operating cash flow$764.4K-16.8%

CapEx$248.6K-22.8%

Free cash flow$515.8K-13.6%

Market cap$147.9M+3.8%

Enterprise value$141.69M+1.3%

P/E17.4×-1.5×

P/S1.9×-0.3×

Operating margin14.4%-0.6pp

Net margin10.9%-1.4pp

FCF margin6.1%—

Return on equity19.1%-5.6pp

Debt / equity0.3×-0.1×

Current ratio3.4×+0.7×

Reported directly by Legacy Reserves in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The official record: Legacy Reserves’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Legacy Reserves's share based compensation arrangement by share based payment award options exercisable number?: Legacy Reserves (LGCY) reported share based compensation arrangement by share based payment award options exercisable number of $1.65M in Q1 2026.
How has Legacy Reserves's share based compensation arrangement by share based payment award options exercisable number changed year-over-year?: Legacy Reserves's share based compensation arrangement by share based payment award options exercisable number increased by 11.2% year-over-year, from $1.48M to $1.65M.